260 related articles for article (PubMed ID: 30810839)
81. Identification of Novel Stemness-based Subtypes and Construction of a Prognostic Risk Model for Patients with Lung Squamous Cell Carcinoma.
Shen F; Li F; Ma Y; Song X; Guo W
Curr Stem Cell Res Ther; 2024; 19(3):400-416. PubMed ID: 37455452
[TBL] [Abstract][Full Text] [Related]
82. Oncogene-specific advocacy groups bring a patient-centric perspective to studies of lung cancer.
Dolgin E
Nature; 2020 Nov; 587(7834):S16-S17. PubMed ID: 33208972
[No Abstract] [Full Text] [Related]
83. Functional impact of titin (TTN) mutations in ocular surface squamous neoplasia.
Djulbegovic MB; Uversky VN; Karp CL; Harbour JW
Int J Biol Macromol; 2022 Jan; 195():93-101. PubMed ID: 34838574
[TBL] [Abstract][Full Text] [Related]
84. Expression profiling of ubiquitin-related genes in LKB1 mutant lung adenocarcinoma.
Wang G; Bie F; Qu X; Yang X; Liu S; Wang Y; Huang C; Wang K; Du J
Sci Rep; 2018 Sep; 8(1):13221. PubMed ID: 30185829
[TBL] [Abstract][Full Text] [Related]
85. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
[TBL] [Abstract][Full Text] [Related]
86. Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma.
Zhu YC; Xu CW; Zhang QX; Wang WX; Lei L; Zhuang W
Chin Med J (Engl); 2019 Dec; 132(24):3015-3017. PubMed ID: 31809319
[No Abstract] [Full Text] [Related]
87. Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.
Deng S; Lu X; Zhang Z; Meng R; Li M; Xia S
J Cell Mol Med; 2021 Jul; 25(14):6652-6663. PubMed ID: 34080290
[TBL] [Abstract][Full Text] [Related]
88. Social, Genetics and Histopathological Factors Related to
Gomes FC; Figueiredo ERL; Araújo EN; Andrade EM; Carneiro CDL; Almeida GM; Dias HAAL; Teixeira LIB; Almeida MT; Farias MF; Linhares NA; Fonseca NLD; Pereira YDS; Melo-Neto JS
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239452
[TBL] [Abstract][Full Text] [Related]
89. Effects of SVEP1 on Lung Squamous Cell Carcinoma and its Association with Tumor Mutation Burden, Prognosis, and Immune Regulation.
Luo Y; Zhang M; Wang Z; Li Z; Chen X; Cao J; Que J; Chen L; Deng X
Comb Chem High Throughput Screen; 2023; 26(2):313-329. PubMed ID: 35306983
[TBL] [Abstract][Full Text] [Related]
90. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
91. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
92. Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma.
Li J; Xiong S; He P; Liang P; Li C; Zhong R; Cai X; Xie Z; Liu J; Cheng B; Chen Z; Liang H; Lao S; Chen Z; Shi J; Li F; Feng Y; Huo Z; Deng H; Yu Z; Wang H; Zhan S; Xiang Y; Wang H; Zheng Y; Lin X; He J; Liang W
Neoplasia; 2024 Aug; 54():101013. PubMed ID: 38850835
[TBL] [Abstract][Full Text] [Related]
93. Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas.
Menor M; Zhu Y; Wang Y; Zhang J; Jiang B; Deng Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):24. PubMed ID: 30704450
[TBL] [Abstract][Full Text] [Related]
94. Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung.
Malanga D; Scrima M; De Marco C; Fabiani F; De Rosa N; De Gisi S; Malara N; Savino R; Rocco G; Chiappetta G; Franco R; Tirino V; Pirozzi G; Viglietto G
Cell Cycle; 2008 Mar; 7(5):665-9. PubMed ID: 18256540
[TBL] [Abstract][Full Text] [Related]
95. Comprehensive genomic and prognostic analysis of the IL‑17 family genes in lung cancer.
Liao T; Fan J; Lv Z; Xu J; Wu F; Yang G; Huang Q; Guo M; Hu G; Zhou M; Duan L; Wang S; Jin Y
Mol Med Rep; 2019 Jun; 19(6):4906-4918. PubMed ID: 31059089
[TBL] [Abstract][Full Text] [Related]
96. Research on circadian clock genes in non-small-cell lung carcinoma.
Qiu M; Chen YB; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jun; 36(6):739-750. PubMed ID: 31014124
[TBL] [Abstract][Full Text] [Related]
97. Co-mutation of TP53 and TTN is Correlated with the Efficacy of Immunotherapy in Lung Squamous Cell Carcinoma.
Ying K; Zou L; Wang D; Wang R; Qian J
Comb Chem High Throughput Screen; 2023 Oct; ():. PubMed ID: 37904553
[TBL] [Abstract][Full Text] [Related]
98. Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression.
Zhou C; Wang Y; Wang Y; Lei L; Ji MH; Zhou G; Xia H; Yang JJ
Aging (Albany NY); 2021 Feb; 13(6):8706-8719. PubMed ID: 33619234
[TBL] [Abstract][Full Text] [Related]
99. Genome-scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma.
Li YY; Yang C; Zhou P; Zhang S; Yao Y; Li D
J Cell Biochem; 2018 Nov; 119(11):8909-8921. PubMed ID: 30105759
[TBL] [Abstract][Full Text] [Related]
100. The Prognosis of Lung Cancer With Different Metastatic Patterns.
Okauchi S; Watanabe H; Yamada H; Sato S; Miyazaki K; Kodama T; Satoh H; Hizawa N
Anticancer Res; 2020 Jan; 40(1):421-426. PubMed ID: 31892596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
